Bioengineering Today: Imaging the Heart
Feb 23, 2018 21:09 pm UTC| Business
Washington, D.C., Feb. 23, 2018 -- Cardiovascular disease is the number one killer in the United States and around the world. February is American Heart Month, and to honor healthy heart health awareness, Bioengineering...
Cannabis Consortium has Secured a Steady Supply of Medical Grade Oil for its Products
Feb 23, 2018 21:08 pm UTC| Business
COCONUT CREEK, Fla., Feb. 23, 2018 -- Via OTC PR Wire -- Bahamas Development Corporation (OTC:BDCI) subsidiary company Cannabis Consortium, Inc., has partnered with a Cannabis Distillate to supply all of its Oil needs...
SP+ Elects Alice M. Peterson to Board of Directors
Feb 23, 2018 21:07 pm UTC| Business
CHICAGO, Feb. 23, 2018 -- SP Plus Corporation (SP+), (Nasdaq:SP), a leader in parking management, ground transportation and ancillary services, today announced that Alice M. Peterson has been elected to serve on its...
IRIDEX Issues Voluntary Recall of TruFocus LIO Premiere™ Laser Indirect Ophthalmoscope
Feb 23, 2018 21:06 pm UTC| Business
MOUNTAIN VIEW, Calif, Feb. 23, 2018 -- On February 23, 2018, IRIDEX Corporation (“Company”) initiated a voluntary recall of a specific laser accessory called the TruFocus LIO Premiere™. The LIO is a headmounted...
Navios Maritime Acquisition Corporation Receives Continued Listing Standards Notice From NYSE
Feb 23, 2018 21:05 pm UTC| Business
MONACO, Feb. 23, 2018 -- Navios Maritime Acquisition Corporation Inc. (“Navios Acquisition” or the “Company”) (NYSE:NNA) announced today that on February 13, 2018, the Company was notified by the New York Stock...
Golden Arrow Reports on Puna Operations Financials
Feb 23, 2018 21:03 pm UTC| Business
VANCOUVER, British Columbia, Feb. 23, 2018 -- Golden Arrow Resources Corporation (TSX-V:GRG) (FSE:GAC) (OTCQB:GARWF) (“Golden Arrow” or the “Company”) is pleased to report that the fourth quarter and year end 2017...
Feb 23, 2018 21:00 pm UTC| Business
Geneva, Switzerland and Boston, MA - February 23, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions...